CareLit Fachartikel

Treatment of haemophilia A in Tunisia: efficacy and inhibitor study

Mliki, M.; Abdelkafi, S.; Bouslama, M.; Zaïer, M.; Mahjoub, T.; Kortas, M.; Ghachem, L.; Yacoub, S.; Houissa, B. · Zeitschrift für Orthopädie und Unfallchirurgie · 2003 · Heft 03 · S. 144 bis 148

Dokument
614588
CareLit-ID
Jahr
2003
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Zeitschrift für Orthopädie und Unfallchirurgie
Autor:innen
Mliki, M.; Abdelkafi, S.; Bouslama, M.; Zaïer, M.; Mahjoub, T.; Kortas, M.; Ghachem, L.; Yacoub, S.; Houissa, B.
Ausgabe
Heft 03 / 2003
Jahrgang 23
Seiten
144 bis 148
Erschienen: 2003-01-01 00:00:00
ISSN
0720-9355;2567-5761
DOI
10.1055/s-0037-1619585

Zusammenfassung

SummaryCryoprecipitate is the principal type of factor VIII (FVIII) concentrate used for treating haemophilia A in Tunisia. Allergic reactions, viral transmission, and inhibitor formation remain the most serious complications of FVIII therapy. The aims of the study presented here were to evaluate the efficacy of FVIII therapy, to investigate the inhibitor prevalence, and the factors which may affect inhibitor formation in our haemophilia A patients. Plasma samples were screened for FVIII inhibitors by the Bethesda method. 30 minutes FVIII recovery was also determined for each patient. In this prospective study,…

Schlagworte

Affect Aged Zeitschrift für Orthopädie und Unfallchirurgie